Abstract: Methods of making cross sectional, functionally-graded munitions propellants exhibiting various distributions of particle concentrations and burn rate, including having a fast burning core and slower burning outer layer(s). Unlike prior art methods of preparing such munitions, propellants prepared according to our inventive method(s) may be performed substantially as a single extrusion step or as a few processing steps, without requiring the time, expense and/or difficulties that characterized familiar, laminating methods and methods which use multiple extruders. Our inventive method advantageously employs a demixing phenomenon that, prior to our inventive application and teaching, has been considered quite undesirable in the preparation of propellants where uniformity and well-mixedness have been propellant attributes widely sought after.
Type:
Grant
Filed:
February 11, 2005
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
David Fair, Dilhan M. Kalyon, Sam Moy, Leon R. Manole
Abstract: A device for the safe handling of nonhuman primates includes a transparent elongated body having a top end and a bottom end. A ventilated lid is attached to the top end of the body by means of a hinge and includes a positive locking arrangement. The bottom end of the body is removably connected to a base which has first and second springs attached thereto. The body includes a plurality of apertures into which are positioned a plurality of inserts. Inserts proximate the bottom of the body include projections which are positioned under the first and second springs to maintain the body on the base.
Type:
Grant
Filed:
May 7, 2008
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: The present invention relates to a vaccine for increasing the immunogenicity of a tumor antigen thus allowing treatment of cancer, as well as a vaccine that increases the immunogenicity of a viral antigen, thus allowing treatment of viral infection, including immunodeficiency virus (HIV) infection. In particular, the present invention provides a fusion protein comprising a viral chemokine fused to either a tumor antigen or viral antigen which is administered as either a protein or nucleic acid vaccine to elicit an immune response effective in treating cancer or effective in treating or preventing viral infection.
Type:
Grant
Filed:
September 17, 2001
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Secretary of the Department of Health and Human Services
Abstract: An apparatus for sensing and processing a magnetic flux signal comprising: an odd number of at least three fluxgate modules, a summer, and a processor. Each fluxgate module is configured to generate a module response signal upon receiving the magnetic flux signal. The fluxgate modules are circularly coupled to each other such that only one-way signal flow is allowed between them. The summer is configured to sum the response signals from each fluxgate module into a summed signal. The processor is configured to receive and process the summed signal.
Type:
Grant
Filed:
September 21, 2007
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Secretary of the Navy
Inventors:
Visarath In, Adi R. Bulsara, Yong (Andy) Kho, Joseph D. Neff, Antonio Palacios, Salvatore Baglio, Vincenzo Sacco
Abstract: A warhead fuse mechanism is used to prevent an accidental explosive event of a warhead by positioning a booster lead carrier, having a booster lead segment, positioned between the warhead detonator and warhead explosive. In a safe position the booster lead segment is off-set from alignment with the warhead detonator and warhead explosive. The warhead fuse is armed by rotating either the warhead detonator or booster lead carrier to align the warhead detonator and booster lead segment to form a detonation chain between the warhead detonator and warhead explosive.
Type:
Grant
Filed:
July 3, 2007
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Secretary of the Navy
Inventors:
Gerrit Sutherland, Charles Stevens Coffey, Frederica A. Coffey, legal representative, Harold Sandusky
Abstract: An electrolytic fluid antenna comprising: a first current probe having an aperture; a pump having a nozzle, wherein the pump is configured to pump electrolytic fluid out the nozzle and through the aperture; and a first transceiver operatively coupled to the current probe.
Type:
Grant
Filed:
May 12, 2008
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Secretary of the Navy
Abstract: An elastic space-deployable boom of carbon fiber reinforced plastic or other resilient material having an open substantially triangular cross-section when deployed and stowed with a flattened cross-section about a circular hub.
Type:
Grant
Filed:
October 22, 2007
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Secretary of the Air Force
Abstract: A chemical composition is provided having the formula: M—SnOx.yH2O M is a platinum group metal and x and y are positive numbers. The hydrous platinum tin oxide may be used in the cathode of a fuel cell as a catalyst for oxygen reduction.
Type:
Grant
Filed:
October 20, 2003
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Secretary of the Navy
Abstract: A graphical user interface for a semantic normalizer of natural language comprising: a link to a preference menu, in which a user may set the semantic normalizer to operate in a predictive or learning mode; an input textbox disposed to display user-typed text in a first font color and user-spoken text in a second font color; a semantic echo textbox disposed to display semantically normalized text in a third font color, wherein the first, second, and third font colors are different from each other; graphical buttons that are only enabled when the semantic normalizer is in learning mode, wherein the graphical buttons may be selected by the user after the user has been prompted by the semantic normalizer to verify the accuracy of the semantically normalized text, the graphical buttons comprising a “Yes” button, a “No” button, and an “Enter Correction” button.
Type:
Grant
Filed:
January 30, 2007
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Secretary of the Navy
Abstract: Disclosed herein is a pharmacophore model for arthropod repellent activity and methods of making and using thereof. The pharmacophore comprises two hydrophobic aliphatic functions, one aromatic function and one hydrogen bond acceptor function. The pharmacophore model was made using a test set of arthropod repellent compounds. Also disclosed are arthropod repellent compounds identified by screening databases with the pharmacophore model. Also disclosed are methods of repelling arthropods from a surface or area. Compositions and formulations comprising the compounds of the present invention as well as objects having the compounds of the present invention are disclosed.
Type:
Grant
Filed:
December 24, 2008
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
Raj K. Gupta, Apurba K. Bhattacharjee, Donna Ma Lee
Abstract: A method and product thereof made by: reacting a carborane-containing compound and an aromatic compound (below) with a crosslinker having at least two silyl hydrogen atoms. R is alkyl, aryl, alkylaryl, haloalkyl, or haloaryl group. Cb is a divalent carboranyl group. U is an unsaturated hydrocarbon group. Ar1 and Ar2 are each a first aromatic group or a bisphenol residue, where at least one of Ar1 and Ar2 is the first aromatic group. Each Ar is a second aromatic group. Each n is a nonnegative integer. The values n? and n? are positive integers and m, w, x, y, and z are 0 or 1. If y is 0 than x and z are 0 and w is 1, and if y is 1 than x and z have different values and w equals z.
Type:
Grant
Filed:
April 12, 2010
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Secretary of the Navy
Abstract: Systems, methods and apparatus are provided in which an autonomic unit or element is quiesced. A quiesce component of an autonomic unit can cause the autonomic unit to self-destruct if a stay-alive reprieve signal is not received after a predetermined time.
Type:
Grant
Filed:
September 21, 2006
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Administrator of the National Aeronautics and Space Administration
Abstract: A tool-less chain coupling link has first and second body members releasably joined together. A first hinge pin is movably positioned within corresponding openings in the first and second body members. A first hinge pin keeper member is pivotally attached to the first body member and movably attached to the first hinge pin. A second hinge pin is movably positioned within other corresponding openings in the first and second body members. A second hinge pin keeper member is pivotally attached to the second body member and movably attached to the second hinge pin. The first and second hinge pin keeper members can be pivoted in a first direction to withdraw the first and second hinge pins, respectively, a sufficient distance to allow the first and second body members to be released from each other.
Type:
Grant
Filed:
May 14, 2009
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: The invention relates to compositions and methods for treating or preventing vascular dementia in a mammal comprising mucosal administration of an amount of E-selectin polypeptide sufficient to induce bystander immune tolerance in the mammal. Another aspect of the invention relates to compositions useful for treating or preventing vascular dementia.
Type:
Grant
Filed:
February 28, 2008
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Department of Health and Human Services
Abstract: A method and system for detecting and classifying anomalies in a medical image. During anomaly detection, once the intensity of an image pixel crosses a detection threshold, the pixel is detected and linking inputs are provided to its nearest-neighbor pixels. The linking inputs increase the intensities of the neighbor pixels, which may result in the detection of these nearest-neighbor pixels if their linked intensities are above the threshold. Each detected anomaly is classified by determining a genetic response surface methodology (GRSM) model for the detected anomaly, determining a cancerous GRSM model from a database of cancerous anomalies, and comparing the cancerous GRSM model to the GRSM model for the detected anomaly to classify the detected anomaly as cancerous or non-cancerous.
Type:
Grant
Filed:
January 26, 2006
Date of Patent:
March 1, 2011
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: A method for reducing/eliminating basal plane dislocations from SiC epilayers is disclosed. An article having: an off-axis SiC substrate having an off-axis angle of no more than 6°; and a SiC epitaxial layer grown on the substrate. The epitaxial layer has no more than 2 basal plane dislocations per cm2 at the surface of the epitaxial layer. A method of growing an epitaxial SiC layer on an off-axis SiC substrate by: flowing a silicon source gas, a carbon source gas, and a carrier gas into a growth chamber under growth conditions to epitaxially grow SiC on the substrate in the growth chamber. The substrate has an off-axis angle of no more than 6°. The growth conditions include: a growth temperature of 1530-1650° C.; a pressure of 50-125 mbar; a C/H gas flow ratio of 9.38×10?5-1.5×10?3; a C/Si ratio of 0.5-3; a carbon source gas flow rate during ramp to growth temperature from 0 to 15 sccm; and an electron or hole concentration of 1013-1019/cm3.
Type:
Application
Filed:
August 20, 2010
Publication date:
February 24, 2011
Applicant:
The Government of the United States of America, as represented by the Secretary of the Navy
Inventors:
Rachael L. Myers-Ward, David Kurt Gaskill, Brenda L. VanMil, Robert E. Stahlbush, Charles R. Eddy, JR.
Abstract: A new method is disclosed for the exfoliation of hexagonal boron nitride into mono- and few-layered nanosheets (or nanoplatelets, nanomesh, nanoribbons). The method does not necessarily require high temperature or vacuum, but uses commercially available h-BN powders (or those derived from these materials, bulk crystals) and only requires wet chemical processing. The method is facile, cost efficient, and scalable. The resultant exfoliated h-BN is dispersible in an organic solvent or water thus amenable for solution processing for unique microelectronic or composite applications.
Type:
Application
Filed:
August 24, 2009
Publication date:
February 24, 2011
Applicant:
United States of America as represented by the Administrator of the National Aeronautics and Spac
Abstract: A countercurrent chromatography apparatus includes a plurality of plates, at least one plate (16) having first and second interleaved spiral flow channels (52, 54, 56, 58) therein. Each spiral flow channels (52, 54, 56, 58) has a first end (I1, I2, I3, I4) near the central axis and a second ends (O1, O2, O3, O4) near the periphery. The outlet of the first channel (O1) is connected to the inlet of the second channel (I2) by a connecting channel (72). Septa may be provided between the plates to connect the spiral channels of one plate to the spiral channels of the next plate.
Type:
Grant
Filed:
March 25, 2003
Date of Patent:
February 22, 2011
Assignee:
The United States of America as represented by the Department of Health and Human Services
Abstract: Optical cells include a spacer formed of a hydrocarbon-resistant polymer, so that fluids such as hydrocarbons and alcohols can be introduced to a sample space, or include a fluid inlet and a heated inlet tube, so that a humid gas can be introduced to the sample space without condensation occurring. Optical cells can be used with, for example, solid, gel, and liquid samples. Measurements can be performed with various selected sample gaps of an optical cell.
Type:
Grant
Filed:
July 18, 2007
Date of Patent:
February 22, 2011
Assignee:
The United States of America as represented by the Department of Health and Human Services